Day: March 28, 2022

Dave & Buster’s Reports Fourth Quarter 2021 and Full-Year Financial Results; Company Provides First Quarter FY 2022 Business Update and Outlook

Written by Customer Service on March 28, 2022. Posted in Earnings Releases And Operating Results.

DALLAS, March 28, 2022 (GLOBE NEWSWIRE) — Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an owner and operator of entertainment and dining venues, today announced financial results for its fourth quarter and fiscal year ended January 30, 2022. As of January 30, 2022, all of the Company’s 142 stores in the United States and Puerto Rico were open, including 1 new store opened during the quarter. The Company’s two Canadian stores were required by provincial mandate to temporarily close in early January. Both Canadian stores reopened in early Fiscal 2022. Key Fourth Quarter 2021 HighlightsRevenue decreased by 1.2% from the fourth quarter of 2019 to $343.1 million compared with $116.8 million in the fourth quarter of 2020 and $347.2 million in...

Hometown Financial Group, Inc. to Acquire Randolph Bancorp, Inc.

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

EASTHAMPTON and QUINCY, Mass., March 28, 2022 (GLOBE NEWSWIRE) — Hometown Financial Group, Inc. (“Hometown”), the multi-bank holding company for bankESB, bankHometown and Abington Bank, and Randolph Bancorp, Inc. (NASDAQ: RNDB) (“Randolph”), the bank holding company for Envision Bank, jointly announced today that they have entered into a definitive merger agreement pursuant to which Hometown will acquire Randolph. Under the terms of the merger agreement, which has been unanimously approved by both boards of directors, Randolph shareholders will receive $27.00 in cash for each share of Randolph common stock. The total transaction value is approximately $146.5 million. The merger is anticipated to close in the fourth quarter of 2022, subject to certain conditions, including the receipt of required regulatory approvals, shareholder...

WSFS Financial Corporation to Hold 2022 Annual Meeting Virtually on May 11

Written by Customer Service on March 28, 2022. Posted in Public Companies.

In the next phase of succession planning, Mark A. Turner steps aside from WSFS Board after 15 years of dedicated board service WILMINGTON, Del., March 28, 2022 (GLOBE NEWSWIRE) — WSFS Financial Corporation (NASDAQ: WSFS) (“WSFS”), the parent company of WSFS Bank, announced that it will host its 2022 Annual Meeting of Stockholders virtually at 4 p.m. EDT on May 11, 2022. Stockholders at the close of business on the record date, March 18, 2022, are entitled to attend the Annual Meeting. In addition, this will be the last Annual Meeting for Mark A. Turner as a WSFS Board Member. He has been with WSFS since 1996 and served on the Board of Directors from 2007 to 2022. This represents the final step in WSFS’ long-planned CEO succession. As former Chairman, President and CEO, Turner’s business decisions, entrepreneurial approach and leadership...

Werner Enterprises Board Member Carmen Tapio Named Nebraska Honoree of USA TODAY’s Women of the Year

Written by Customer Service on March 28, 2022. Posted in Public Companies.

Carmen Tapio, founder and CEO of North End Teleservices, LLC and Werner Director and ESG Committee Chair, recognized among USA TODAY’s Women of the Year. OMAHA, Neb., March 28, 2022 (GLOBE NEWSWIRE) — Werner Enterprises (Nasdaq: WERN), a premier transportation and logistics provider, is proud to recognize the accomplishment of its Director and ESG Committee Chair, Carmen Tapio, for being named Nebraska’s honoree of USA TODAY’s Women of the Year. Tapio is the founder and CEO of North End Teleservices, LLC, which is currently the largest Black-owned business in Nebraska. In 2020, Tapio was appointed to the Werner Enterprises Board of Directors. “Carmen has been an incredible contributor to our board of directors,” said Chairman, President and CEO Derek Leathers. “It’s an honor to have her as part of our corporate governance team.” The...

First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19

Written by Customer Service on March 28, 2022. Posted in Public Companies.

BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced the continued enhancement of the intellectual property (IP) portfolio governing niclosamide as a treatment for COVID-19-related GI infections. The Company has filed U.S. Patent and Patent Cooperation Treaty (PCT) applications entitled “Treatment of Long Haulers Syndrome with Niclosamide” (U.S. Application No. 17/703,626 and PCT Application No. PCT/US22/21736). Niclosamide is a widely prescribed small molecule with anti-inflammatory and antiviral properties that has been safely used on millions of people worldwide. First Wave BioPharma...

Raymond James Financial To Acquire SumRidge Partners

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

ST. PETERSBURG, Fla., March 28, 2022 (GLOBE NEWSWIRE) — Raymond James Financial, Inc. (NYSE: RJF) announced today that it has reached an agreement to acquire SumRidge Partners, LLC, a top ranked, technology-driven fixed income market maker specializing in investment-grade and high-yield corporate bonds, municipal bonds and institutional preferred securities. The transaction is subject to certain regulatory and other closing conditions. The addition of SumRidge Partners to the firm’s Fixed Income Capital Markets (FICM) division adds an innovative institutional market-making operation with sophisticated trading technologies and risk management tools. Founded in 2010 with the vision of becoming a premier, technology-enabled fixed income market maker, SumRidge Partners currently ranks among the top liquidity providers for cash trading...

Aileron Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

Written by Customer Service on March 28, 2022. Posted in Earnings Releases And Operating Results.

Several anticipated catalysts in 2022 aim to advance Aileron’s vision to bring chemoprotection against multiple toxicities to all patients with p53-mutated cancer regardless of type of cancer or chemotherapyExpected readouts for Phase 1b trial in p53-mutated non-small cell lung cancer (NSCLC): Interim data in 2Q22; topline results in 4Q22 Anticipated milestones for planned Phase 1b clinical trial in p53-mutated neoadjuvant breast cancer: Initiation in 1H22; interim results in 4Q22Cash, cash equivalents and investments as of December 31, 2021 expected to fund operations into the fourth quarter of 2023BOSTON, Mass., March 28, 2022 (GLOBE NEWSWIRE) — Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients’ lives, today...

Stratus Properties Inc. and Ryman Hospitality Properties, Inc. Provide Update on Anticipated Closing Date for Sale of Block 21

Written by Customer Service on March 28, 2022. Posted in Mergers And Acquisitions.

NASHVILLE, Tenn., March 28, 2022 (GLOBE NEWSWIRE) — Stratus Properties Inc. (NASDAQ: STRS) (“Stratus”) and Ryman Hospitality Properties, Inc. (NYSE: RHP) (“Ryman”) announced today that the anticipated closing date for the previously announced sale of Block 21 by Stratus to Ryman has been extended, as the parties complete the process of obtaining the remaining required approvals of the assumption of the property’s existing mortgage loan by the purchaser. The acquisition is now expected to close sometime prior to June 1, 2022, subject to the timely satisfaction or waiver of various closing conditions, including the final consent of the loan servicers to the assumption of the existing loan by the purchaser, the consent of the hotel operator, an affiliate of Marriott, to the assumption of the hotel operating agreement by the purchaser,...

U.S. Energy Corp. Announces Full Year and Fourth Quarter 2021 Results; Declares First Quarterly Cash Dividend Payment

Written by Customer Service on March 28, 2022. Posted in Dividend Reports And Estimates.

HOUSTON, March 28, 2022 (GLOBE NEWSWIRE) — U.S. Energy Corp. (NASDAQCM: USEG) (“U.S. Energy” or the “Company”) today announced results for the full year and fourth quarter ended December 31, 2021. In addition, the Company’s board of directors declared a quarterly cash dividend of $0.0225 per share of common stock, payable on May 2, 2022, to shareholders of record as of April 15, 2022. HighlightsExecuted Purchase and Sale Agreements for previously announced transformative acquisitions on October 4, 2021, which closed subsequent to year-end on January 5, 2022; Full year 2021 production of 123,165 barrel of oil equivalent (“BOE”), or average daily production of 337 BOEPD, an increase of 55% compared to full year 2020; Full year 2021 revenue of $6.7 million, an increase of 186% compared to full year 2020; 4Q2021 production of 31,929...

Cullinan Oncology Announces Clinical and Regulatory Update for CLN-081 in NSCLC EGFR Exon 20 Patients

Written by Customer Service on March 28, 2022. Posted in Public Companies.

Confirmed overall response rate improves to 41% at 100mg BID dose level Continued favorable safety and tolerability profile observed in heavily pre-treated patients Pivotal study initiation expected 2H 2022 following food effect study CAMBRIDGE, Mass., March 28, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (Cullinan), a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for cancer patients, today announced clinical and regulatory updates on its lead program, CLN-081. CLN-081 is being evaluated in an ongoing Phase 1/2a clinical trial in non-small cell lung cancer (NSCLC) patients whose tumors harbor epidermal growth factor receptor (EGFR) exon 20 insertion mutations that have progressed on or after prior therapy. Clinical Update: In the ongoing Phase 1/2a study, CLN-081...

Day: March 28, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice